Iben Daugaard

895 total citations
20 papers, 682 citations indexed

About

Iben Daugaard is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Iben Daugaard has authored 20 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Iben Daugaard's work include MicroRNA in disease regulation (9 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (6 papers). Iben Daugaard is often cited by papers focused on MicroRNA in disease regulation (9 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (6 papers). Iben Daugaard collaborates with scholars based in Denmark, United States and Poland. Iben Daugaard's co-authors include Thomas B. Hansen, Lise Lotte Hansen, Henrik Hager, Lasse S. Kristensen, Jørgen Kjems, Lotte Victoria Winther Stagsted, Kirsten Grønbæk, Irene M. Pedersen, Mette Dahl and Dimitrios G. Zisoulis and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Scientific Reports.

In The Last Decade

Iben Daugaard

20 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iben Daugaard Denmark 14 567 403 57 54 45 20 682
Doaa Fathi Egypt 15 404 0.7× 417 1.0× 73 1.3× 29 0.5× 30 0.7× 21 586
Emanuele Monteleone Italy 8 779 1.4× 540 1.3× 87 1.5× 69 1.3× 23 0.5× 10 929
Li‐Ting Diao China 12 563 1.0× 308 0.8× 86 1.5× 55 1.0× 24 0.5× 20 702
Stefania Oliveto Italy 11 448 0.8× 271 0.7× 52 0.9× 46 0.9× 19 0.4× 18 629
Jayanth Kumar Palanichamy India 15 641 1.1× 491 1.2× 71 1.2× 72 1.3× 23 0.5× 53 841
Ömer An Singapore 16 628 1.1× 210 0.5× 61 1.1× 55 1.0× 27 0.6× 30 740
Wenwei Hu China 15 903 1.6× 706 1.8× 104 1.8× 62 1.1× 56 1.2× 24 1.1k
Shaoqiang Wang China 15 384 0.7× 275 0.7× 73 1.3× 46 0.9× 26 0.6× 30 557
Gergely Buglyó Hungary 10 287 0.5× 209 0.5× 55 1.0× 28 0.5× 34 0.8× 19 463
Eleonora Zonta France 11 466 0.8× 274 0.7× 132 2.3× 26 0.5× 55 1.2× 13 714

Countries citing papers authored by Iben Daugaard

Since Specialization
Citations

This map shows the geographic impact of Iben Daugaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iben Daugaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iben Daugaard more than expected).

Fields of papers citing papers by Iben Daugaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iben Daugaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iben Daugaard. The network helps show where Iben Daugaard may publish in the future.

Co-authorship network of co-authors of Iben Daugaard

This figure shows the co-authorship network connecting the top 25 collaborators of Iben Daugaard. A scholar is included among the top collaborators of Iben Daugaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iben Daugaard. Iben Daugaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hussmann, Dianna, Anna Starnawska, Iben Daugaard, et al.. (2022). Methylation microarray-based detection of clinical copy-number aberrations in CLL benchmarked to standard FISH analysis. Genomics. 114(6). 110510–110510. 1 indexed citations
2.
Hussmann, Dianna, Anna Starnawska, Iben Daugaard, et al.. (2021). IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load. Haematologica. 107(4). 877–886. 5 indexed citations
3.
Daugaard, Iben, et al.. (2020). miR-151a enhances Slug dependent angiogenesis. Oncotarget. 11(23). 2160–2171. 7 indexed citations
4.
Stagsted, Lotte Victoria Winther, et al.. (2019). Noncoding AUG circRNAs constitute an abundant and conserved subclass of circles. Life Science Alliance. 2(3). e201900398–e201900398. 57 indexed citations
5.
Sevrioukov, Evgueni A., Adam Idica, Eddie Park, et al.. (2019). miR-128 Restriction of LINE-1 (L1) Retrotransposition Is Dependent on Targeting hnRNPA1 mRNA. International Journal of Molecular Sciences. 20(8). 1955–1955. 13 indexed citations
6.
Bochnakian, Aurore, Anjie Zhen, Dimitrios G. Zisoulis, et al.. (2019). Interferon-Inducible MicroRNA miR-128 Modulates HIV-1 Replication by Targeting TNPO3 mRNA. Journal of Virology. 93(20). 26 indexed citations
7.
Dahl, Mette, Iben Daugaard, Thomas B. Hansen, et al.. (2018). Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies. Laboratory Investigation. 98(12). 1657–1669. 112 indexed citations
8.
Sanders, Katie, Adam Idica, Aurore Bochnakian, et al.. (2018). miR-128 inhibits telomerase activity by targeting TERT mRNA. Oncotarget. 9(17). 13244–13253. 28 indexed citations
9.
Daugaard, Iben, Dianna Hussmann, Thomas Kielsgaard Kristensen, et al.. (2018). Chronic Lymphocytic Leukemia Patients with Heterogeneously or Fully Methylated LPL Promotor Display Longer Time to Treatment. Epigenomics. 10(9). 1155–1166. 4 indexed citations
10.
Daugaard, Iben & Thomas B. Hansen. (2017). Biogenesis and Function of Ago-Associated RNAs. Trends in Genetics. 33(3). 208–219. 103 indexed citations
11.
Idica, Adam, Evgueni A. Sevrioukov, Dimitrios G. Zisoulis, et al.. (2017). MicroRNA miR-128 represses LINE-1 (L1) retrotransposition by down-regulating the nuclear import factor TNPO1. Journal of Biological Chemistry. 292(50). 20494–20508. 24 indexed citations
12.
Daugaard, Iben, et al.. (2017). The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma. Experimental and Molecular Pathology. 102(3). 484–491. 35 indexed citations
13.
Daugaard, Iben, Morten T. Venø, Yan Yan, et al.. (2017). Small RNA sequencing reveals metastasis-related microRNAs in lung adenocarcinoma. Oncotarget. 8(16). 27047–27061. 24 indexed citations
14.
Daugaard, Iben, Katie Sanders, Adam Idica, et al.. (2017). miR-151a induces partial EMT by regulating E-cadherin in NSCLC cells. Oncogenesis. 6(7). e366–e366. 62 indexed citations
15.
Stagsted, Lotte Victoria Winther, Iben Daugaard, & Thomas B. Hansen. (2017). The agotrons: Gene regulators or Argonaute protectors?. BioEssays. 39(4). 8 indexed citations
16.
Daugaard, Iben, Diana Domínguez, Lasse S. Kristensen, et al.. (2016). Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma. Scientific Reports. 6(1). 35807–35807. 57 indexed citations
17.
Daugaard, Iben, et al.. (2015). The influence of DNA degradation in formalin-fixed, paraffin-embedded (FFPE) tissue on locus-specific methylation assessment by MS-HRM. Experimental and Molecular Pathology. 99(3). 632–640. 25 indexed citations
18.
Daugaard, Iben, Brita Singers Sørensen, Andreas Carus, et al.. (2014). Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation. Oncoscience. 1(5). 367–374. 61 indexed citations
19.
Kristensen, Lasse S., Iben Daugaard, Mariann Christensen, et al.. (2010). Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products. Human Mutation. 31(12). 1366–1373. 29 indexed citations
20.
Daugaard, Iben. (1986). [Psychiatry--Italy. The best prevention is the closing of psychiatric hospitals].. PubMed. 86(30). 18–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026